ZA922810B - New combination treatment for benign prostatic hyperplasia - Google Patents

New combination treatment for benign prostatic hyperplasia

Info

Publication number
ZA922810B
ZA922810B ZA922810A ZA922810A ZA922810B ZA 922810 B ZA922810 B ZA 922810B ZA 922810 A ZA922810 A ZA 922810A ZA 922810 A ZA922810 A ZA 922810A ZA 922810 B ZA922810 B ZA 922810B
Authority
ZA
South Africa
Prior art keywords
combination treatment
benign prostatic
prostatic hyperplasia
new combination
new
Prior art date
Application number
ZA922810A
Inventor
Glen J Gormley
J Gormley Glen
Elizabeth Stoner
Stoner Elizabeth
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZA922810B publication Critical patent/ZA922810B/en

Links

ZA922810A 1991-04-17 1992-04-16 New combination treatment for benign prostatic hyperplasia ZA922810B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68672091A 1991-04-17 1991-04-17

Publications (1)

Publication Number Publication Date
ZA922810B true ZA922810B (en) 1992-11-25

Family

ID=24757455

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA922810A ZA922810B (en) 1991-04-17 1992-04-16 New combination treatment for benign prostatic hyperplasia

Country Status (1)

Country Link
ZA (1) ZA922810B (en)

Similar Documents

Publication Publication Date Title
US5419763B1 (en) Prostatic drug-delivery catheter
IL101243A0 (en) Pharmaceutical compositions for treatment of benign prostatic hyperplasia
EP0667769A4 (en) Use of alpha-1c specific compounds to treat benign prostatic hyperplasia.
IL101574A0 (en) Combination pharmaceutical compositions for the treatment of benign prostatic hyperplasia
GB9208339D0 (en) Treatment composition
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
ZA952763B (en) Use of alpha-1C specific compounds to treat benign prostatic hyperplasia
EP0855910A4 (en) Conjugates useful in the treatment of benign prostatic hyperplasia
ZA954984B (en) Compositions and methods for the treatment of tumors
IL101245A0 (en) Pharmaceutical compositions for the treatment of prostatic cancer
HUT73678A (en) Compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
ZA983968B (en) Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia.
EP0462668A3 (en) New 17beta-aminobenzoyl-4-aza-5alpha-androst-1-en-3-ones as benign prostatic hypertrophy agents
GB9320676D0 (en) Treatment fo wood
IL137954A0 (en) Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
GB9102796D0 (en) Water treatment agent
EP0633781A4 (en) Compositions and methods for treating benign prostatic hypertrophy.
EP0733365A3 (en) Use of benzoquinolin-3-ones for the treatment and prevention of prostatic cancer
ZA922810B (en) New combination treatment for benign prostatic hyperplasia
AU2959892A (en) Apparatus for thermal treatment of the prostate
GB9127056D0 (en) Gas treatment
IL122316A0 (en) Melatonin agonists for treating benign prostatic hyperplasia
GB9100970D0 (en) Acne treatment composition
ZA922010B (en) Improved method of treatment for benign prostatic hyperplasia
EP0461658A3 (en) Thermotherapy apparatus